Jaguar health announces appointment of pravin chaturvedi, ph.d., as chief scientific officer

Dr. chaturvedi continues to serve as chair of company's scientific advisory board dr. chaturvedi continues to provide leadership to the development of two crofelemer pipeline indications, with anticipated key milestones in the next 12-15 months. san francisco, ca / accesswire / april 5, 2022 / jaguar health, inc. (nasdaq:jagx) (jaguar) today announced that pravin chaturvedi, phd, a pharmaceutical veteran and leading clinical development expert, has been appointed chief scientific officer (cso) and chair of the scientific advisory board (sab) of jaguar.
JAGX Ratings Summary
JAGX Quant Ranking